MusclePharm Corporation Proceeds from Convertible Debt
MusclePharm Corporation reported Proceeds from Convertible Debt of $2.46 million for the 12-month period ending 2021-12-31, per its 10-K/A filed 2022-05-04.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2022-05-04
- MusclePharm Corporation proceeds from convertible debt for fiscal 2021 was $2.46M.
- MusclePharm Corporation proceeds from convertible debt for fiscal 2017 was $871.00K.
| Period end | Proceeds from Convertible Debt 6 month | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 12 month |
|---|---|---|---|
| 2021-12-31 | $2.46M 10-K/A · filed 2022-05-04 | ||
| 2018-09-30 | $31.68M 10-K · filed 2020-08-25 | ||
| 2017-12-31 | $871.00K 10-K · filed 2020-08-25 | ||
| 2012-12-31 | $519.95K 10-Q/A · filed 2014-01-13 | ||
| 2012-06-30 | $519.95K 10-Q/A · filed 2012-09-13 | ||
| 2011-12-31 | $4.68M 10-Q/A · filed 2012-09-13 |